导航
| 股票代码 | 股票名称 | 仓位比例 | 涨跌 | 贡献增长率 |
| 600276 | 恒瑞医药 | 9.41% | 5.28% | 0.4968% |
| 300760 | 迈瑞医疗 | 7.55% | 2.14% | 0.1616% |
| 603259 | 药明康德 | 4.82% | 1.26% | 0.0607% |
| 600436 | 片仔癀 | 3.32% | 0.86% | 0.0286% |
| 300015 | 爱尔眼科 | 2.79% | 0.83% | 0.0232% |
| 688271 | 联影医疗 | 2.68% | 2.81% | 0.0753% |
| 300122 | 智飞生物 | 2.59% | -11.99% | -0.3105% |
| 000538 | 云南白药 | 2.01% | -0.90% | -0.0181% |
| 000661 | 长春高新 | 1.84% | 0.45% | 0.0083% |
| 300896 | 爱美客 | 1.73% | 2.03% | 0.0351% |
| 重仓股合计:38.74%, 重仓股贡献增长率: 0.561%, 总持股仓位:93.57%,修正增长率: | ||||
| 日期 | 实际增长率 | 预估增长率 |
| 2024-04-22 | 0.57% | 0.08% |
| 2024-04-19 | -0.73% | -1.04% |
| 2024-04-18 | -0.49% | -0.70% |
| 2024-04-17 | 1.42% | 1.75% |
| 2024-04-16 | -1.44% | -1.28% |
| 2024-04-15 | 1.14% | 1.34% |
| 2024-04-12 | -0.70% | -1.15% |
| 2024-04-11 | -0.52% | -1.18% |
| 基金名称 | 单位净值 | 增长率 |
| 国泰创新医疗混合发起A | 0.7836 | 3.1086% |
| 国泰创新医疗混合发起C | 0.7818 | 3.1086% |
| 国泰价值先锋股票A | 0.7124 | 2.2761% |
| 港股通50ETF | 0.8054 | 1.6276% |
| 医疗ETF | 0.3958 | 1.4322% |
| 国泰优势行业混合 | 1.4057 | 1.2162% |
| 国泰新经济 | 1.6751 | 1.1516% |
| 国泰成长价值混合C | 0.5653 | 1.1507% |
| 国泰成长价值混合A | 0.5739 | 1.1109% |
| 国泰价值先锋股票C | 0.6866 | 1.0814% |
| 基金名称 | 单位净值 | 增长率 |
| 0.7768 | 6.0755% | |
| 嘉实互融精选股票 | 1.1036 | 5.8227% |
| 1.1014 | 5.8227% | |
| 金鹰多元策略混合 | 0.7749 | 5.7248% |
| 金鹰鑫富混合A | 0.9681 | 5.7184% |
| 金鹰鑫富混合C | 0.9994 | 5.7184% |
| 平安核心优势混合A | 1.4472 | 5.3872% |
| 平安核心优势混合C | 1.3818 | 5.3872% |
| 鹏华创新增长一年持有期混合A | 0.9227 | 4.9623% |
| 鹏华创新增长一年持有期混合C | 0.9090 | 4.9623% |
